1082 related articles for article (PubMed ID: 31911458)
1. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
2. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation.
Samus M; Seelige R; Schäfer K; Sorokin L; Vestweber D
J Leukoc Biol; 2018 Oct; 104(4):787-797. PubMed ID: 29791026
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
4. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
5. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
6. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
8. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
9. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system.
Pierson ER; Stromnes IM; Goverman JM
J Immunol; 2014 Feb; 192(3):929-39. PubMed ID: 24367024
[TBL] [Abstract][Full Text] [Related]
10. Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system.
Chen Q; Liu Y; Lu A; Ni K; Xiang Z; Wen K; Tu W
J Autoimmun; 2017 Feb; 77():1-10. PubMed ID: 28341037
[TBL] [Abstract][Full Text] [Related]
11. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Zhang Y; Han J; Wu M; Xu L; Wang Y; Yuan W; Hua F; Fan H; Dong F; Qu X; Yao R
J Neuroimmune Pharmacol; 2019 Sep; 14(3):493-502. PubMed ID: 31065973
[TBL] [Abstract][Full Text] [Related]
13. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
14. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
[TBL] [Abstract][Full Text] [Related]
15. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
16. Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.
Ji Z; Fan Z; Zhang Y; Yu R; Yang H; Zhou C; Luo J; Ke ZJ
J Immunol; 2014 Sep; 193(5):2157-67. PubMed ID: 25063874
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
19. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
[TBL] [Abstract][Full Text] [Related]
20. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
